| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/03/2004 | US20040106657 Indolyl derivatives |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106638 Sulfonamide and sulfamide substituted imidazoquinolines |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106632 5-(4-{2-'(6-methoxy-pyrimidin-4-yl)methyl-amino)-ethoxy}-benzyl)-thiazolidin-2,4-dione sodium salt |
| 06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors |
| 06/03/2004 | US20040106607 New compounds |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 06/03/2004 | US20040106520 A pplying to plants; controlling weeds |
| 06/03/2004 | DE10254439A1 Tubulysine, Herstellungsverfahren und Tubulysin-Mittel Tubulysins, manufacturing methods and means tubulysin |
| 06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | CA2506735A1 Indole derivatives as somatostatin agonists or antagonists |
| 06/03/2004 | CA2506503A1 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases |
| 06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/02/2004 | EP1423363A1 Oral antidiabetic agents |
| 06/02/2004 | EP1423120A1 2h-phthalazin-1-ones and methods for use thereof |
| 06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
| 06/02/2004 | EP1182202B1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 06/02/2004 | EP1161424B1 New diazole derivatives as serotonergic agents |
| 06/02/2004 | EP1114032B1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/02/2004 | CN1501980A Degradation of epothilones and ethynyl substituted epothilones |
| 06/02/2004 | CN1501962A Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501773A Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 06/02/2004 | CN1152023C Substituted polycyclic aryl and hetero aryl uracils as anticoagulant |
| 06/01/2004 | US6743923 A benzylidene derivatives used for osteoclast formation inhibition, a nitrogen monoxide production inhibition, and a transcription factor nf kappa b supressing agent |
| 06/01/2004 | US6743811 Oxazalidinone compounds and methods of preparation and use thereof |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743804 Quinoline derivatives as NK3 antagonists |
| 06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
| 06/01/2004 | US6743792 Antiinflammatory agents |
| 06/01/2004 | US6743787 For therapy of metabolic disorders mediated by insulin resistance or hyperglycemia in a mammal |
| 06/01/2004 | CA2266016C Tricyclic inhibitors of farnesyl protein transferase |
| 05/27/2004 | WO2004043955A1 Rhodanine derivatives and pharmaceutical compositions containing them |
| 05/27/2004 | WO2004043954A2 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same |
| 05/27/2004 | WO2004043953A1 Pyrimidine compounds |
| 05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | WO2004043948A1 Sulfonamides |
| 05/27/2004 | WO2004043947A1 Novel pyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043928A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/27/2004 | WO2004043927A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 05/27/2004 | WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| 05/27/2004 | WO2004043917A1 Sulfonamides |
| 05/27/2004 | WO2004043908A1 Process for converting a cis-trans mixture of substituted benzylidene amines into the pure cis isomer |
| 05/27/2004 | WO2004043463A2 Sulfonamides |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043354A2 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043349A2 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 05/27/2004 | WO2004026254A3 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 05/27/2004 | WO2004024058A3 Molecules with antitumor activity and chemical synthesis |
| 05/27/2004 | WO2004014881A3 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 05/27/2004 | WO2004013234A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/27/2004 | WO2004012735A3 New effector conjugates, process for their production and their pharmaceutical use |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003062388A9 Inhibition of rna function |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102495 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 05/27/2004 | US20040102494 Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them |
| 05/27/2004 | US20040102485 Tartrate salt of thiazolidinedione derivative |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102457 Central nervous system disorders; anxiolytic agents; antidepressants; attention deficit disorders; Alzheimer's diseases |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | DE10252719A1 New tubulysin analogs, useful for treating tumor or cancer diseases, immunologically induced or autoimmune diseases, inflammatory diseases or rheumatoid arthritis or for surface modification of implants |
| 05/27/2004 | DE10252102A1 New 3-(piperidino- or -piperazino-alkyl)-indole derivatives, are 5HT-1A and/or 5HT-1D agonists and 5-HT reuptake inhibitors, useful e.g. for treating anxiety, depression or neurodegenerative diseases |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |